go back

Colon Cancer Gene Activity Recurrence Test

Delaware rates for HCPCS 81525

A laboratory test run on colon tumor tissue removed at surgery that measures how active a group of genes is in the cancer cells. The result is a score estimating the chance the cancer will return, which helps the patient and oncologist decide whether chemotherapy after surgery is worthwhile.

Rates data updated July 2026.

Facilitymedian $3,548 · 10th–90th $3,548$3,5480%50%$3,548Professionalmedian $2,089 · 10th–90th $324$9,3330%20%10th90th$2,089$500.0$1.0K$2.0K$5.0K$10.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Aetna
Setting
Professional
Modifier
Global
Typical Low
$323.59
Median
$2,089.30
Typical High
$9,332.54
Cigna
Setting
Facility
Modifier
Global
Typical Low
$2,041.74
Median
$2,041.74
Typical High
$2,041.74
Cigna
Setting
Professional
Modifier
Global
Typical Low
$2,089.30
Median
$2,089.30
Typical High
$2,089.30
United
Setting
Professional
Modifier
Global
Typical Low
$1,318.26
Median
$1,862.09
Typical High
$4,677.35